Study 203120: A Randomized, Blinded, Vehicle-Controlled, Dose-Finding Study of GSK2894512 Cream for the Treatment of Plaque Psoriasis
Phase of Trial: Phase II
Latest Information Update: 15 Nov 2017
At a glance
- Drugs Tapinarof (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline
- 19 Jan 2017 Status changed from recruiting to completed.
- 04 Feb 2016 Planned number of patients changed from 258 to 270, as reported by ClinicalTrials.gov.
- 04 Feb 2016 Planned end date changed from 1 Aug 2016 to 1 Sep 2016, as reported by ClinicalTrials.gov.